J&J’s Medtech Business Experiencing Rebound in Demand for Surgeries Among Older Adults An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. J&J’s Medtech Division Experiencing Surge in Demand J&J’s medtech division provides devices for surgeries, orthopedics, and vision. The company is benefiting from a rebound … Read more
Highest-ranking article on Sickle Cell Gene Therapies The Challenges and Benefits of Sickle Cell Gene Therapies The Impact of Sickle Cell Disease on Patients and Their Treatment Options The crippling episodes of pain from the genetic blood disorder make life unpredictable for patients like Michael Goodwin. Sickle cell has forced him to leave his job … Read more
Las pharmaceutical that market their medicines in New York will not be able to continue raising the costs of their products without any control, because from now on the manufacturers of certain prescription medicines will have a brake, since they must notify the Department of Financial Services about any proposal to increase prices that they … Read more
Las pharmaceutical that market their medicines in New York will not be able to continue raising the costs of their products without any control, because from now on the manufacturers of certain prescription medicines will have a brake, since they must notify the Department of Financial Services about any proposal to increase prices that they … Read more
The Mexican Association of Research Industries Pharmaceutical (Amif) stated that the New Molecules Committee (CMN) gave approval to vaccines against covid-19 Pfizer and Modern. Same as now They wait for the time of legal registration by the Federal Commission for Protection against Health Risks (Cofepris), which is 45 days. In a conference, Cristobal Thompson, executive … Read more
Advancements in cancer therapies have been nothing short of remarkable in recent years, with ongoing research and development paving the way to more effective and innovative treatments. Now, a collaboration between Moderna and Merck may offer even greater hope for patients with cancer. The two pharmaceutical giants have created a unique combo cancer-vaccine treatment that … Read more
The COVID-19 pandemic has put the world on edge and has led to a scramble by doctors and researchers to find an effective treatment for the virus. In the search for possible treatments, corticosteroids have emerged as a common option for reducing inflammation in patients with severe COVID-19 symptoms. However, new research highlights the risks … Read more
(CNN) – The COVID-19 vaccines created at least nine new billionaires after stocks in the companies that produce the doses soared. At the top of the list of new billionaires are Stephane Bancel, CEO of Moderna and Ugur Sahin, CEO of BioNTech, which produced one of the vaccines together with Pfizer. Both CEOs now have … Read more
Testing for coronavirus in India – – The Comptroller General of India has approved 2-DG for emergency use. The first batch of a new drug for the treatment of COVID-19 coronavirus, 2-deoxy-D-glucose (2-DG), has entered circulation in India. It is reported by Xinhua Monday, May 17th. It is indicated that this drug was developed by … Read more
Laggard pharmaceuticals could be about to receive a post-pandemic booster shot. The actions of GlaxoSmithKline, Novartis or Sanofi have suffered during the confinements, as routine procedures and treatments have been postponed. But with the economic reopening they should recover. The health sector has had its share of winners for Covid, such as Moderna. But some … Read more